Table 2.
Sequencing Primers for Sanger Sequencing
Region | Part | Primer name | Sequence |
---|---|---|---|
1 | 1 | CoV-2 S_Seq1-F1a | 5′-CAAATCCAATTCAGTTGTCTTCC-3′ |
CoV-2 S_Seq1-F1b | 5′-TGGAGGAATACAAATCCAATTCA-3′ | ||
CoV-2 S_Seq1-R1a | 5′-TAAAGCCGAAAAACCCTGAG-3′ | ||
CoV-2 S_Seq1-R1b | 5′-TGAGGGAGATCACGCACTAA-3′ | ||
2 | CoV-2 S_Seq1-F2a | 5′-GGACCTTGAAGGAAAACAGG-3′ | |
CoV-2 S_Seq1-F2b | 5′-TGCGAATAATTGCACTTTTGA-3′ | ||
CoV-2 S_Seq1-R2a | 5′-CTTTCCAGTTTGCCCTGGAG-3′ | ||
CoV-2 S_Amp-R1b∗ | 5′-AACGCAGCCTGTAAAATCATC-3′ | ||
2 | 1 | CoV-2 S_Seq2-F1a | 5′-TGCAGATTCATTTGTAATTAGAGG-3′ |
CoV-2 S_Amp-F2b∗ | 5′-CCGCATCATTTTCCACTTTT-3′ | ||
CoV-2 S_Seq2-R1a | 5′-TGCACCAATGGGTATGTCAC-3′ | ||
CoV-2 S_Seq2-R1b | 5′-CGCATATACCTGCACCAATG-3′ | ||
2 | CoV-2 S_Seq2-F2a | 5′-CTGCACAGAAGTCCCTGTTG-3′ | |
CoV-2 S_Seq2-F2b | 5′-CCCTGTTGCTATTCATGCAG-3′ | ||
CoV-2 S_Seq2-R2a | 5′-TGTACCCGCTAACAGTGCAG-3′ | ||
CoV-2 S_Seq2-R2b | 5′-GGTTGGCAATCAATTTTTGG-3′ | ||
3 | 1 | CoV-2 S_Seq3-F1a | 5′-ACTGTTTTGCCACCTTTGCT-3′ |
CoV-2 S_Seq3-F1b | 5′-TTAACGGCCTTACTGTTTTGC-3′ | ||
CoV-2 S_Seq3-R1a | 5′-AACCAGTGTGTGCCATTTGA-3′ | ||
CoV-2 S_Seq3-R1b | 5′-GACAAATGGCAGGAGCAGTT-3′ | ||
2 | CoV-2 S_Seq3-F2a | 5′-CTTCCCTCAGTCAGCACCTC-3′ | |
CoV-2 S_Seq3-F2b | 5′-GAGGCTGAAGTGCAAATTGA-3′ | ||
CoV-2 S_Seq3-R2a | 5′-TAGCGCGAACAAAATCTGAA-3′ | ||
CoV-2 S_Seq3-R2b | 5′-AGGGAGTGAGGCTTGTATCG-3′ |
Each amplicon was designed to be sequenced in two overlapping parts, with two forward and reverse primers for each part. The primers used for most samples are in bold; the other primers were used if these primers did not yield usable Sanger sequences.
Two amplification primers were used as sequencing primers if not used to generate the amplicons.